LCD L36021: MolDX: Molecular Diagnostic Tests (MDT) — CGS
Policy LCD-L36021 · Clinical Laboratory
New MolDX policy effective in 2025 may alter billing processes.
Code intelligence
Policy changes, MAC LCD updates, and CMS guidance matched to code 0047U.
Signal breakdown
7 shown · 7 total in platform
Critical
0%
High
43%
Routine
57%
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Policy LCD-L36021 · Clinical Laboratory
New MolDX policy effective in 2025 may alter billing processes.
Policy LCD-L36256 · Clinical Laboratory
New molecular diagnostics policy may impact billing processes.
Policy LCD-L35160 · Clinical Laboratory
New MolDX guidelines may alter MDT billing processes.
Policy LCD-L38292 · Oncology
New genomic assay coverage requires billing team review.
Policy LCD-L38341 · Oncology
New Genomic Classifier Assay impacts prostate cancer billing.
Policy LCD-L38339 · Oncology
New assay coverage may influence prostate cancer billing practices.
Policy LCD-L38303 · Oncology
New genomic classifier coverage supports compliance with updated rates for prostate cancer.
Audit documentation
The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.